Feature | Treatment Planning | July 03, 2018 | By Jeff Zagoudis

This article originally ran as an introduction to the Treatment Planning Systems comparison chart in the July/August 2018 issue. 

 JoVE_Radiation_Planning_Assistant_schematic

A new software developed and recently tested at the MD Anderson Cancer Center demonstrated the ability to largely automate the entire workflow of radiotherapy treatment planning. Such a system may offer a solution to a looming shortage of qualified radiation oncology professionals identified by the research team.

As the incidence of cancer continues to rise worldwide, the demand for radiation therapy services is expected to increase, naturally requiring more radiation oncology staff. A 2014 study found that these staffing demands will be a challenge to meet, particularly for low- and middle-income countries (LMICs). The study projects that worldwide, an additional 12,000 radiation oncologists, 10,000 medical physicists and 29,000 technologists will be needed by 2020.1 The MD Anderson research team believes that an automated system like the one they designed could help mitigate some of these projected staffing deficiencies.

The system, dubbed the Radiation Planning Assistant (RPA), works in tandem with MD Anderson’s existing treatment planning system (Varian Eclipse) and secondary dose verification software (Mobius 3D). All that is needed to start the automated treatment planning process is a treatment plan order approved by the radiation oncologist and a computed tomography (CT) simulation image of the treatment area, approved by the CT technician. The treatment plan order contains all of the relevant information needed to create the plan — basic patient information, prescription, treatment type, etc.

Currently the RPA has only been tested for two specific treatment delivery/cancer site combinations:

•    Volumetric modulated arc therapy (VMAT) for head and neck cancers; and

•    Four-field box plans for patients with cervical cancer.

 

Once the inputs have been approved, the RPA begins automatic plan generation, beginning with contouring. This is the only portion that may require human intervention, depending on the treatment type. For head and neck cancer plans, the radiation oncologist must approve the initial target and normal tissue delineation from the CT image; the contours can be edited if necessary. The RO also delineates the gross tumor volume (GTV) manually at this point. No human intervention is required during cervical cancer treatment planning.

On average, the research team found that head/neck VMAT plans were completed in 46 minutes (for a 2-arc plan), while the 4-field box treatment cervical cancer plans took just 21 minutes. Review of the latter group by an experienced radiation oncologist found that 90-96 percent of the field boxes were clinically appropriate.

Review of the final plans is arguably the most important area of human intervention in the RPA process. The team at MD Anderson designed an illustrated procedure guide for users to check:

•    Marked isocenter and body contour identification;

•    Patient orientation, laterality and treatment site;

•    Field apertures (for 4-field box plans); and

•    Presence of image or dose calculation artifacts.

 

A library of case images was created for each portion of the check guide that plan reviewers can use for reference.

To assess the usability of the RPA, the research team had four non-clinical staff (aka those with limited radiotherapy experience) review a series of 16 cervical cancer plan documents — 12 of which contained intentional errors. The volunteers were able to find all errors related to body contouring, isocenter and dose calculation artifacts. However, they could not identify the one 4-field plan that contained only three fields, nor could they identify small errors in the field apertures. This assessment demonstrated that some plan review work can be assigned to non-specialized staff, but that final review should still be conducted by the radiation oncologists and the physicists.

The study authors eventually hope the RPA will be able to generate treatment plans for all cancer sites and treatment modalities.

 

Reference

1. Datta N.R., Samiei M., Bodis S. Radiation therapy infrastructure and
    human resources in low- and middle-income countries: present
    status and projections for 2020
, International Journal of
    Radiation Oncology Biology Physics, July 1, 2014. DOI: https://doi.org/10.1016/j.ijrobp.2014.03.002

Related Content

News | Radiation Oncology

October 21, 2021 — Novocure announced 15 presentations on Tumor Treating Fields (TTFields) will be featured at the ...

Time October 21, 2021
arrow
News | Radiation Oncology

August 30, 2021 — RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ESTRO ...

Time August 30, 2021
arrow
News | Treatment Planning

August 3, 2021 — LAP announced it has strengthened its partnership with leading integrated oncology care provider ...

Time August 03, 2021
arrow
News | RSNA

July 21, 2021 — Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly ...

Time July 21, 2021
arrow
Feature | Treatment Planning | Information provided by Grand View Research

The rapid increase in global cancer prevalence is driving the demand for innovative and accurate oncology treatment ...

Time July 07, 2021
arrow
News | Oncology Information Management Systems (OIMS)

June 28, 2021 — RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier ...

Time June 28, 2021
arrow
News | Artificial Intelligence

April 7, 2021 — Vysioneer, a leader in artificial intelligence (AI) for cancer care, announced it received the U.S. Food ...

Time April 07, 2021
arrow
News | Treatment Planning

March 10, 2021 — Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image ...

Time March 10, 2021
arrow
Feature | Treatment Planning | By Melinda Taschetta-Millane

The decision to offer radiation after prostatectomy for patients with recurrent prostate cancer is quite complex, and ...

Time March 05, 2021
arrow
Subscribe Now